go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

West Virginia rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $562,341 · 10th–90th $398,107$616,5950%50%10th90th$562,341Professionalmedian $562,341 · 10th–90th $512,861$588,8440%50%10th90th$562,341$500.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$398,107.17
Median
$562,341.33
Typical High
$616,595.00
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$588,843.66
CareSource
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
CareSource
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
United
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
United
Setting
Professional
Modifier
Global
Typical Low
$346,736.85
Median
$512,861.38
Typical High
$660,693.45